Kamal Sharma

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis et al. · JAMA Internal Medicine · 2021 · 486 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

LIM Homeodomain Factors Lhx3 and Lhx4 Assign Subtype Identities for Motor Neurons

Kamal Sharma, Hui Z. Sheng, Karen Lettieri et al. · Cell · 1998 · 444 citations · Full text

Life Sciences, Genetics, Neuroscience +12

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Kanyin Liane Ong, Damian Santomauro, A Bhoomadevi et al. · The Lancet · 2025 · 413 citations · Full text

Public Health, Health Sciences, Epidemiology +16

Autonomic Regulation Therapy via Left or Right Cervical Vagus Nerve Stimulation in Patients With Chronic Heart Failure: Results of the ANTHEM-HF Trial

Rajendra Kumar Premchand, Kamal Sharma, Sanjay Mittal et al. · Journal of Cardiac Failure · 2014 · 378 citations

Medicine, Cardiology, Pharmacotherapy +16

Active Suppression of Interneuron Programs within Developing Motor Neurons Revealed by Analysis of Homeodomain Factor HB9

Joshua P. Thaler, Kathleen A. Harrison, Kamal Sharma et al. · Neuron · 1999 · 361 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17